Bufatas IV Injection

Overview Bufatas IV Injection

Chronic myeloid leukemia and other cancers may be treated with Bufatas IV Injection. This medication is administered intravenously by a healthcare professional, often in conjunction with other anticancer agents, particularly during hematopoietic stem cell transplantation (HSCT). The dosage and duration are determined by your physician and may vary. Strict adherence to the prescribed regimen is crucial to maximize benefits and minimize serious adverse effects. While therapeutic effects might not be immediately apparent, discontinuation should only occur under medical supervision. Common side effects encompass reduced blood cell counts (red blood cells, white blood cells, and platelets), nausea, vomiting, and anorexia. Report any concerning symptoms to your doctor, as management strategies exist. Prior medical conditions, such as bleeding disorders, cardiovascular or hepatic disease, prior radiation exposure, or infections, should be disclosed to your physician. Interactions with other medications are possible; therefore, a complete medication list should be provided. Seek immediate medical attention for unusual bleeding or bruising, dark or bloody stools, or severe sore throat. The medication's effect on blood cell counts elevates infection risk, necessitating regular blood tests to monitor blood cell levels, renal, hepatic, and cardiac function. Contraception is recommended for both partners during treatment to prevent pregnancy.

Uses of Bufatas IV Injection

Chronic myelogenous leukemia, a type of blood malignancy

Major Benefits of Bufatas IV Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Bufatas IV Injection:

• Decreased blood cells (red cells, white cells, and platelets)
• Nausea
• Abdominal pain
• Vomiting
• Loss of appetite
• Anxiety
• Decreased magnesium level in blood
• Decreased potassium level in blood
• Diarrhea
• Fever
• Headache
• Increased glucose level in blood
• Insomnia (difficulty in sleeping)
• Stomatitis (Inflammation of the mouth)

How to use Bufatas IV Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Bufatas IV Injection works:

Oncolytic Bufatas, administered intravenously, targets cancerous cells. Its mechanism involves disrupting the genetic integrity (DNA and RNA) of these cells, thereby inhibiting proliferation and growth.

What if you forget to take Bufatas IV Injection :

Should you forget a Bufatas IV Injection, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.